Loading organizations...
KetoSwiss is a biotech startup based in Basel, Switzerland, focused on developing ketone-based therapies, including novel medical foods like MigraKet, to improve brain energetics for preventing metabolic migraines and other neurological diseases. The company aims to enhance the quality of life for individuals with brain health conditions through science-based products and services. KetoSwiss has successfully raised USD 4.8 million in pre-series A funding to advance its research and product development initiatives. Its work centers on addressing neurological conditions with a focus on preventive therapies. The organization was founded by Dr. Elena Gross, who also serves as CEO and CSO, though the exact founding year is not publicly known. Its business model centers on biotech startup funded through venture investments, including pre-series A rounds.
KetoSwiss has raised $4.8M across 1 funding round.
KetoSwiss has raised $4.8M in total across 1 funding round.
KetoSwiss has raised $4.8M across 1 funding round. Most recently, it raised $4.8M Pre-Series A in August 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 10, 2023 | $4.8M Seed Plus | William K Warren Foundation | Baszucki Group, Healthspan Ventures, Ortho Innovations, R42 Group | Announced |
KetoSwiss has raised $4.8M in total across 1 funding round.
KetoSwiss's investors include William K Warren Foundation, Baszucki Group, Healthspan Ventures, Ortho Innovations, R42 Group.
